Table 3 ENE in ALN and nodal burden.
From: Prognostic value of extranodal extension in axillary lymph node-positive breast cancer
Nodal burden | ENE | p-value | ||||||
---|---|---|---|---|---|---|---|---|
Negative (244) | Positive (158) | Negative vs Positive | ≤ 2 mm vs > 2 mm | ≤ 3 mm vs > 3 mm | ||||
PD-ENE | CD-ENE | |||||||
≤ 2 mm (98) | > 2 mm (60) | ≤ 3 mm (112) | > 3 mm (46) | |||||
N stage | ||||||||
N1 | 87 | 14 | 6 | 13 | 7 | |||
N2 | 120 | 43 | 28 | 50 | 21 | |||
N3 | 37 | 41 | 26 | 49 | 18 | < 0.001 | 0.843 | 0.779 |
No. of removed axillary lymph nodes | ||||||||
≤ 20 | 154 | 61 | 26 | 63 | 24 | |||
> 20 | 90 | 37 | 34 | 49 | 22 | 0.111 | 0.427 | 0.645 |
Median metastatic tumor diameter (cm) | ||||||||
≤ 0.7 | 120 | 29 | 21 | 36 | 14 | |||
> 0.7 | 124 | 69 | 39 | 76 | 32 | < 0.001 | 0.497 | 0.835 |
Peri lymph node vascular invasion | ||||||||
No | 142 | 40 | 24 | 46 | 18 | |||
Yes | 102 | 58 | 36 | 66 | 28 | 0.001 | 0.748 | 0.823 |
No. of ENE foci | ||||||||
1–2 | 71 | 45 | 82 | 34 | ||||
> 2 | 27 | 15 | 30 | 12 | 0.283 | 0.929 |